INTRODUCTION

CELIAC DISEASE DIAGNOSIS

Simultaneous detection of anti Tissue Transglutaminase, anti-gliadin and anti-Deaminated Peptide of Gliadin.

Celiac disease is suspected when individuals have signs or symptoms of malabsorption or malnutrition. The presence of anti-tissue transglutaminase antibodies is highly reliable in diagnosing celiac disease. Anti-gliadin antibodies are less reliable nevertheless they are useful in monitoring the response to treatment

• FIDIS™ Celiac DPG IgA kit is designed for the simultaneous detection of human IgA isotype antibodies directed against Tissue Transglutaminase, Gliadin and Deaminated Peptide of Gliadin.
• FIDIS™ Celiac DPG IgG kit is designed for the simultaneous detection of human IgG isotype antibodies directed against Tissue Transglutaminase, Gliadin and Deaminated Peptide of Gliadin.

PRODUCT ADVANTAGES

Eficient and flexible

• High throughput testing for rapid diagnosis
• Improved turn around time of results
• Up to 91 patients in 90 min
• Simultaneaous multiple analysis of 10 auto-antibodies per patient in 90 min

Automation

• Save laboratories from manual assays
• Easily adapted to automation using CARIS™
• All useful information included in barcode
• Ability of multi-batch with all range of FIDIS™ reagents: FIDIS™ Vasculitis, Celiac A, Celiac G, Thyro, Rheuma, Gastric

Fast and simple interpretations

• Using FIDIS™ analyser and MLX-BOOSTER software:
  • results automatically calculated
  • efficient and friendly
  • intuitive interface
• Results given in
  • Arbitrary Unit/mL (AU/mL)
  

TESTPRINCIPLE

FIDIS™ Celiac kits are a quantitative homogeneous fluorescent-based microparticles immunoassay using Luminex® technology.

ANTIGENS

* Internal Standard Bead confirms the presence of sera and conjugate.

QUALITY

• Immuno-Trol by bmd is the first multi parametric control for auto-immune disease diagnosis
• Validate your results using Immuno-Trol II (Cat # HM 037)
• Simultaneous Multiple analysis saves laboratories time and money

HANDELSFORM